Simplex Trading’s Co-Diagnostics CODX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-325
Closed -$1.64K 9210
2025
Q4
$1.64K Sell
325
-306
-48% -$3.33K ﹤0.01% 7895
2025
Q3
$6K Buy
631
+440
+230% +$4.09K ﹤0.01% 8172
2025
Q2
$1K Buy
191
+129
+208% +$1.21K ﹤0.01% 8280
2025
Q1
$0 Sell
62
-855
-93% -$16.3K ﹤0.01% 8643
2024
Q4
$20K Buy
917
+559
+156% +$17.7K ﹤0.01% 6674
2024
Q3
$13K Sell
358
-1,803
-83% -$69.2K ﹤0.01% 6992
2024
Q2
$81K Buy
2,161
+1,775
+460% +$64.6K ﹤0.01% 5590
2024
Q1
$12K Sell
386
-435
-53% -$15.8K ﹤0.01% 7460
2023
Q4
$32K Buy
+821
New +$28.9K ﹤0.01% 6496
2023
Q2
Sell
-4
Closed -$153 9088
2023
Q1
$0 Sell
4
-870
-100% -$69.7K ﹤0.01% 9142
2022
Q4
$66K Buy
874
+323
+59% +$30.2K ﹤0.01% 5531
2022
Q3
$53K Buy
+551
New +$77.1K ﹤0.01% 6362
2022
Q2
Sell
-159
Closed -$24.2K 10080
2022
Q1
$29K Sell
159
-358
-69% -$74.1K ﹤0.01% 7801
2021
Q4
$138K Sell
517
-591
-53% -$155K ﹤0.01% 5724
2021
Q3
$276K Buy
1,108
+119
+12% +$34.7K ﹤0.01% 5056
2021
Q2
$244K Sell
989
-91
-8% -$23.4K ﹤0.01% 5351
2021
Q1
$309K Buy
+1,080
New +$431K ﹤0.01% 4108
2020
Q4
Sell
-1
Closed -$370 8415
2020
Q3
$0 Sell
1
-564
-100% -$290K ﹤0.01% 7856
2020
Q2
$328K Buy
565
+132
+30% +$60.3K ﹤0.01% 3422
2020
Q1
$98K Buy
+433
New +$75.1K ﹤0.01% 4388

Other funds holding CODX

Simplex Trading's CODX Position: Q1 2026 in Review

Simplex Trading sold out of Co-Diagnostics (CODX) in Q1 2026, closing a stake of 325 shares — an estimated $1.64K sold.

Simplex Trading first reported a position in CODX in Q1 2020 and held it in 20 quarters. The position peaked at $328K in Q2 2020. 14 funds tracked by Wall St. Rank hold CODX as of Q1 2026.

  • Simplex Trading reported no remaining Co-Diagnostics position as of Q1 2026 after selling out during the quarter.
  • Simplex Trading sold 325 Co-Diagnostics shares in Q1 2026, an estimated $1.64K.
  • Simplex Trading first reported a position in Co-Diagnostics in Q1 2020 and held it in 20 quarters.
  • Simplex Trading's Co-Diagnostics position peaked at $328K in Q2 2020.
  • 14 funds tracked by Wall St. Rank held Co-Diagnostics as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.